The obligate intracellular lifestyle of apicomplexan parasites necessitates an invasive phase underpinned by timely and spatially controlled secretion of apical organelles termed micronemes. In Toxoplasma gondii, extracellular potassium levels and other stimuli trigger a signaling cascade culminating in phosphoinositide-phospholipase C (PLC) activation, which generates the second messengers diacylglycerol (DAG) and IP 3 and ultimately results in microneme secretion. Here we show that a delicate balance between DAG and its downstream product, phosphatidic acid (PA), is essential for controlling microneme release. Governing this balance is the apicomplexan-specific DAG-kinase-1, which interconverts PA and DAG, and whose depletion impairs egress and causes parasite death. Additionally, we identify an acylated pleckstrin-homology (PH) domain-containing protein (APH) on the microneme surface that senses PA during microneme secretion and is necessary for microneme exocytosis. As APH is conserved in Apicomplexa, these findings highlight a potentially widely used mechanism in which key lipid mediators regulate microneme exocytosis.
INTRODUCTION
Active host cell entry is an essential step in the propagation of obligate intracellular parasitism by apicomplexan parasites, members of which include the major etiologic agents of malaria (Plasmodium spp.) and toxoplasmosis (Toxoplasma gondii) . Underpinning this process is the release of apical secretory organelles termed micronemes, secretion of which is a prerequisite for gliding motility, invasion, and egress from infected cells (reviewed in Sharma and Chitnis, 2013) . Despite its central role in infectivity, our current understanding of the molecular mechanisms governing microneme secretion is sparse. Microneme exocytosis is known to follow changes in extracellular potassium levels (Singh et al., 2010) , implicates cyclic GMP-dependent protein kinase G (PKG) (Brochet et al., 2014 ) and phosphoinositide regulation (Brochet et al., 2014) , and responds to an increase in intracellular calcium concentration (Brochet et al., 2014; Garg et al., 2013; Singh et al., 2010; Singh and Chitnis, 2012; Wiersma et al., 2004) . PKG activity promotes formation of the phosphoinositide-phospholipase C (PI-PLC) substrate PI (4,5) P 2 (Brochet et al., 2014) , implicating PI-PLC as the downstream mediator of PKG activity. Concordantly, P. falciparum PI-PLC transcription is upregulated during late blood stages, and the P. berghei homolog is refractory to genetic deletion (Raabe et al., 2011) . Inhibitor studies suggest that PI-PLC acts on PI (4,5) P 2 to generate the second messengers IP 3 and DAG and stimulates Ca 2+ release from the endoplasmic reticulum (ER) or other internal stores (Singh et al., 2010) through unidentified receptors (reviewed in Budu and Garcia, 2012) . Ethanol stimulation of T. gondii microneme secretion also triggers an increase in calcium, likely as a result of PI-PLC-derived IP 3 (Carruthers et al., 1999; Lovett et al., 2002) . Members of the calcium-dependent protein kinase (CDPK) family are critically involved downstream of this signaling cascade (Garrison et al., 2012; Lourido et al., 2012; McCoy et al., 2012; reviewed in (Holder et al., 2012) . Ultimately, a fusion event believed to involve SNARE-like proteins such as DOC2.1 (Farrell et al., 2012; Jean et al., 2014) enacts microneme exocytosis. With a view to better deciphering microneme exocytosis, we have focused here on diacylglycerol (DAG) and phosphatidic acid (PA), downstream products of PI-PLC signaling at the parasite plasma membrane (PPM). DAG is interconverted to PA via DAG kinases (DGKs) and PA phosphatases (PAPs). In mammalian systems, PA is involved in signal transduction (ChasserotGolaz et al., 2010) , membrane dynamics (Kooijman et al., 2003) , and exocytosis (reviewed in Ammar et al., 2013; Chasserot-Golaz et al., 2010) , thus providing a precedent for PA to also play a role in microneme exocytosis in the Apicomplexa. We have identified and functionally characterized both the enzyme mediator of PA production and the corresponding PAsensor underpinning an essential mechanism of microneme exocytosis conserved across the Apicomplexa.
RESULTS AND DISCUSSION

Modulation of PA Levels Plays a Critical Role in T. gondii Microneme Secretion
The importance of PA signaling in microneme secretion was implicated by the putative increase in its precursor (DAG) during PI-PLC signaling ( Figure 1A ). The localization of PA-generating enzymes precludes the involvement of phospholipase D (mitochondrial, http://www.toxodb.org/toxo/) or lysophosphatidic acid acyltransferase (ER) (Lindner et al., 2014) , solely implicating DGKs as priority candidates for generation of PA at the PPM (Figures 1A and S1A-S1C).
We first utilized commercially available DGK (R59022) (de Chaffoy de Courcelles et al., 1985) and PAP inhibitors (propranolol) to probe this pathway, hypothesizing that blocking PA production would hamper microneme secretion, while blocking PA conversion to DAG would enhance microneme secretion ( Figure 1A ). These inhibitors were used in parallel for egress (Figure 1B) , invasion (Figure 1C) , gliding ( Figure 1D ), and microneme secretion assays ( Figures 1E-1L ). As hypothesized, R59022 blocked parasite egress ( Figure 1B ), invasion ( Figure 1C ), gliding ( Figure 1D ), and microneme exocytosis ( Figure 1E ). Concordantly, promoting PA accumulation by blocking PAP-activity with propranolol stimulated parasite egress ( Figure 1B ), gliding motility (Figure 1D) , and microneme secretion ( Figures 1F-1L ). Importantly, propranolol acts most significantly when used in a buffer mimicking extracellular potassium concentrations that enable basal microneme secretion in the absence of additional stimuli ( Figures 1F/1H ). These data suggest that for propranolol to effect microneme secretion, the parasite must already be ''primed'' whereby the remainder of the pathway ( Figure 1A ) is already underway; potassium stimulation leading to PI-PLC activity and the concurrent increase in DAG and IP 3 are necessary for propranolol functioning.
Ethanol has previously been linked to microneme secretion and has been proposed to act through stimulating PI-PLC activity (Carruthers et al., 1999; Lovett et al., 2002) . Here we sought to compare the effects of microneme stimulation by propranolol versus ethanol by repeatedly and sequentially stimulating parasites with either 2% ethanol or 250 mM propranolol ( Figure 1G ). While parasites stimulated with ethanol underwent multiple rounds of secretion ( Figure 1G , left panels), those stimulated with propranolol generated only one significant burst of secretion that appeared to completely deplete the micronemal contents ( Figure 1G , right panels), implying that these two compounds have distinct mechanisms of action upon the microneme secretion pathway.
This was further validated through microneme secretion assays completed in buffer mimicking intracellular ionic conditions ( Figure 1H ). In such conditions, only ethanol stimulated microneme secretion, concordant with propranolol being effective only once the remainder of the pathway in Figure 1 is activated and thus PA is being produced. Furthermore, these data imply that unlike ethanol, propranolol cannot stimulate an increase in intracellular calcium levels to elicit microneme secretion. To confirm this, calcium-sensing GCaMP6-expressing tachyzoites (Borges-Pereira et al., 2015) were incubated in either intracellular or extracellular buffer; stimulated with calcium ionophore (A23187), ethanol, or propranolol; and calcium flux was subsequently monitored ( Figure S1D ; Movies S1, S2, S3, and S4). Under all conditions, both A23187 and ethanol stimulated an increase in intracellular (parasite) calcium, whereas propranolol had no effect under either condition ( Figure S1D ; Movies S1, S2, S3, and S4). These data confirm that unlike ethanol, propranolol does not elicit microneme secretion through increasing calcium levels.
Despite the significant effect of propranolol on microneme secretion, invasion efficiency of treated parasites remained unchanged ( Figure 1C , right panel), which is not surprising in light of the gliding assays ( Figure 1D ). Parasite gliding utilizes proteins secreted from the micronemes and assays reveal that in the presence of propranolol, parasites are indeed stimulated to glide; however, gliding activity is altered in a propranolol-concentration-dependent manner. At the maximal concentration of propranolol used in this study (500 mM), gliding trails are predominantly single circles, suggesting that the parasites secrete their micronemes in one burst and can then no longer glide as their micronemal contents are depleted/exhausted, concordant with data shown in Figure 1G . Importantly, as the concentration of propranolol is decreased, parasites increase the amount and type of trails that they deposit (multiple overlapping circles/ random trails) indicating that while microneme secretion is still occurring, these lower concentrations are not sufficient to fully deplete/exhaust the micronemal contents and instead revert the gliding phenotype back to that seen for parasites stimulated (C) R59022 blocks parasite invasion of host cells (left panel), propranolol has no effect (right panel). Error bars represent ±SD for 100 vacuoles counted in triplicate from three biological replicates. (D) Gliding motility is blocked by treatment with R59022 while propranolol stimulates gliding motility in a dose-dependent manner. (E) Ethanol (EtOH, 2%) or propranolol (Prop., 500 mM) stimulation of microneme secretion is blocked by R59022 (30 mM, diminished levels of secreted MIC2 and AMA1). GRA1: control for parasite viability. ESA: excretory secretory antigens. (F) Extracellular parasites were incubated sequentially in buffer mimicking intracellular (Intra.), extracellular (Extra.) or extracellular conditions with 2% EtOH (Extra. +EtOH) in the presence/absence of 500 mM propranolol (± Prop.). Propranolol completely depletes micronemal contents in extracellular buffer. (G) Microneme secretion was sequentially turned on (+) and off (À) three times (left to right) with either 2% EtOH or 500 mM propranolol. MIC2 secretion can be repeatedly stimulated with ethanol, but propranolol triggers only one significant micronemal burst prior to microneme depletion. GRA1 labeling indicates that parasites remain alive following propranolol stimulation. P: pellet. (H) Only ethanol (EtOH, 2%) and not propranolol (Prop., 500 mM) causes microneme secretion in buffer mimicking intracellular conditions (Intra.). Egress; unstimulated parasites in extracellular buffer. (I-L) (I) U73122 (10 mM), (J) U73343 (10 mM), (K) Compound 2 (C2, 1 mM), and (L) BAPTA-AM (10 mM) treatment ablates propranolol-induced microneme secretion. À: Full length protein. Red arrowhead: Processed MIC. EtOH: 2% ethanol. Zap.: 500 mM Zaprinast. Prop.: 500 mM propranolol.
with ethanol ( Figure 1D ). In light of these data, it is not surprising that the invasion efficiency of propranolol treated parasites is not increased compared to untreated parasites.
Confirmation that propranolol impacts upon the pool of PA generated through the PI-PLC pathway ( Figure 1A ) was sought through use of various inhibitors including the DGK inhibitor (R59022, Figure 1E ), PI-PLC inhibitor (U73122, Figure 1I ), its inactive analog U73343 ( Figure 1J ), and PKG inhibitor Compound 2 ( Figure 1K ). These data revealed that blocking production of PA at any point along the pathway outlined in Figure 1A precludes propranolol activity and that it therefore acts upon a pool of PA upregulated during the microneme secretion-signaling pathway. Furthermore, pre-treatment of parasites with a chelator of intracellular calcium (BAPTA-AM, Figure 1L ) blocked ethanol, zaprinast (a phosphodiesterase inhibitor), and propranolol-stimulated microneme secretion, confirming that the production of PA alone cannot override the requirement for a rise in intracellular calcium during this process ( Figure 1L ). These data are in complete agreement with the primary propranolol secretion assays ( Figures 1F/  1H ) and highlight the importance of both arms of the pathway ( Figure 1A ) running concurrently to enact efficient microneme secretion. Overall, these data highlight the importance of a delicate balance between DAG and PA levels during microneme exocytosis. (A and C) Endogenously C-terminally tagged TgPI-PLC (A) or TgPI-PLC cKD (C) localize to apical puncta and peripheral accumulations within intracellular parasites and cluster apically in extracellular parasites. GAP45: parasite periphery. Scale bar 2 mm. (B) TgPI-PLC-ty migrates at the expected size on western blot (125kDa). GRA3: loading control. (D) PI-PLC-ty cKD parasites are regulated by ATc in 48 hr. GRA1: loading control. (E) PI-PLC-ty cKD but not parental DKU80 parasites display a severe growth defect in the absence of PI-PLC-ty (PI-PLC-ty cKD +ATc). (F) IFA of PI-PLC-ty cKD parasites ± ATc (72hr). Parasite morphology is grossly affected following depletion of PI-PLC-ty. GAP45: parasite periphery. MIC2: micronemes. GRA3: dense granules. ROP1: rhoptries. (G) Electron microscopy reveals gross morphological defects in PI-PLC-ty cKD parasites +ATc (bottom two panels) while PI-PLC-ty cKD parasites (ÀATc) appear morphologically normal. P: parasite.
PI-PLC Is Essential for Lytic Stage Growth
The signaling pathway outlined in Figure 1A strongly implicates the importance of PI-PLC in generating both IP 3 and DAG to underpin efficient microneme exocytosis. As such, we appended 3ty-tags to the endogenous C terminus of Tgpiplc (Figures 2A-2D and S2A/S2B) to confirm its localization by indirect immunofluorescence assay (IFA). Previous reports utilized a peptide antibody to localize PI-PLC to the parasite periphery (Fang et al., 2006) ; however, we detected endogenous PI-PLC both in the parasite cytosol and in peripheral and apical accumulations (Figures 2A/2C ). Importantly, PI-PLC-ty appeared to cluster at the parasite apex in extracellular parasites (Figures 2A/2C , bottom panels), concordant with it playing a role in microneme exocytosis. The dual localization of PI-PLC-ty does however suggest that PI-PLC likely plays multiple roles in lipid regulation and does not act exclusively for PPM lipid regulation/microneme exocytosis.
Attempts to knockout Tgpiplc were unsuccessful, and we therefore generated a Tet-inducible knockdown (PI-PLC-ty cKD) that efficiently regulated PI-PLC-ty expression upon addition of anhydrotetracycline (ATc) . Plaque assays clearly demonstrated a significant impact on lytic stage growth in the absence of PI-PLC (Figure 2E) , concordant with PI-PLC playing an essential role within the parasite. Importantly, PI-PLC depletion caused significant morphological abnormalities whereby rosette formation was perturbed and nuclear material was seen within the parasitophorous vacuole (Figures 2F/2G ). This severe phenotype precluded the completion of assays specifically investigating the role of PI-PLC in microneme exocytosis, yet implicated PI-PLC in a vast and as yet incompletely understood signaling cascade.
TgDGK1 Is Essential for Lytic Stage Growth
The effects of both R59022 and propranolol on microneme secretion, combined with the severe deleterious phenotype we observed upon PI-PLC depletion, strongly implicated the presence of a pool of PA at the parasite periphery. Consequently, to confirm that these inhibitors were indeed acting upon a pool of PPM-associated PA, we utilized a yeast-derived molecular probe that binds PA (Spo20pGFP wt ) or its inactive form that does not bind PA (Spo20pGFP mut ) (Nakanishi et al., 2004) by IFA ( Figures 3A/3B ). Spo20pGFP wt but not Spo20pGFP mut specifically labels the parasite periphery ( Figure 3A) ; however, this peripheral localization is abolished by addition of R59022, whereupon Spo20pGFP wt re-localizes to the cytosol ( Figure 3B , bottom panels) confirming both the specificity of Spo20pGFP wt in vivo and the activity of R59022 toward a plasma membrane DGK to block PA production.
Three genes were found to encode putative DGKs in the T. gondii genome (Tgdgk1, ToxoDB: TGME49_202460; Tgdgk2, ToxoDB: TGME49_259830; and Tgdgk3, ToxoDB: TGME49_ 239250), but only Tgdgk1 and Tgdgk3 are conserved across the Apicomplexan phylum ( Figure S1A ). Only TgDGK1 localizes to the parasite periphery ( Figures 3C and S1A ), concordant with a role in peripheral PA generation. Furthermore, TgDGK2 (dense granule/PV localization, Figure S1A ) and TgDGK3 (microneme localization, Figure S1A ) were found to be dispensable for parasite survival (data not shown) while Tgdgk1 was refractory to genetic deletion, and conditional knockdown strategies were implemented. A Tet-inducible knockdown (myc-DGK1cKD) efficiently turned off Tgdgk1 expression upon addition of ATc (Figures 3D/ 3E/3F/3G/3H/3I and S2G-S2L), and plaque assays clearly demonstrated that myc-DGK1 depletion severely impacted the parasite lytic cycle ( Figure 3E ; IFA, Figure 3F ). Electron microscopy ( Figure 3G ) revealed half-empty vacuoles indicative of parasite lysis. The apical positioning of the micronemes was perturbed upon DGK1 depletion as indicated by both apical and posterior MIC2 labeling ( Figure 3F , top right panel), while the remainder of the organelles investigated (mitochondrion, apicoplast, rhoptries, Figures S2I-S2K) localized correctly when the myc-DGK1-depleted parasites remained intact. We believe that dispersal of the micronemes in myc-DGK1-depleted parasites is likely a result of parasite death rather than any direct impact of myc-DGK1 on the positioning of the micronemes themselves. As such, the appearance of the glycosylphosphatidylinositol (GPI) anchored plasma membrane protein SAG1 within the vacuole space was highly suggestive of extensive parasite lysis with PPM destruction ( Figure 3F ). In addition, membranous material seen in the ''parasite-depleted'' vacuoles potentially constitutes a mixture of dead parasites and remnants of the intravacuolar nanotubular network ( Figures 3F and 3G ). Spo20pGFP wt/mut localization within mycDGK1cKD parasites demonstrated that in the absence of myc-DGK1 (myc-DGK1cKD +ATc), Spo20pGFP wt relocates to the nucleus/cytosol, indicating that myc-DGK1 is the most likely regulator of PA at the PPM ( Figure 3H ).
To confirm that these data are indeed due to DGK1 regulation of PA, we quantified the PA in myc-DGK1cKD parasites via gas chromatography-mass spectrometry (GC-MS) after lipid separation with high-performance thin-layer chromatography. When myc-DGK1 is depleted (Figure 3I , +ATc; blue), PA was 10%-40% lower than the parental control (Figure 3I , ÀATc; red).
Furthermore and concordant with our previous findings, we determined that PA levels are also reduced in R59022-treated parasites ( Figure 3J , blue) to a level similar to that seen for myc-DGK1-depleted parasites. While we were able to detect changes in PA levels, these changes were minute, and the total amount of PA in the parasites was subject to large variation between samples (Figures 3I/3J ). These fluctuations are likely due to the central and versatile role of PA as both a major phospholipid precursor and a strong signal transducer in eukaryotic cells (Botté et al., 2012; Chasserot-Golaz et al., 2010 ). The precise origin and role of the total pool of PA in T. gondii is yet to be determined, and such a small decrease in total PA suggests that DGK1 is likely not responsible for the bulk synthesis of PA and is indeed more likely to be serving transient PA synthesis for lipid signaling at the PPM.
Given that these data confirm that DGK1 is involved in PA synthesis at the parasite periphery, we developed an alternative and more synchronized way to deplete TgDGK1 via a fusion with a destabilization domain (DD) (Herm-Gö tz et al., 2007) . To ensure that the N-terminal DD fusion did not impact upon DGK1 function, we first complemented the myc-DGK1cKD strain with an N-terminally DD/HA-tagged copy of TgDGK1 regulated by Shld-1 (myc-DGK1cKD (Comp. DD/HA-DGK1cKD); Figures  S2N-S2P ). Expression of DD/HA-DGK1 in the absence of myc-DGK1 (+Shld-1/+ATc) rescued parasite fitness ( Figure S2N ), demonstrating that the phenotype described for myc-DGK1cKD was indeed due to myc-DGK1 depletion and also that the DD fusion does not interfere with DGK1 function. As expected, DD/HA-DGK1 localized to the parasite periphery ( Figure S2O ), and western blot analyses confirmed that myc-DGK1cKD was still regulated by ATc in the complemented strain ( Figure S2P ).
Next we generated a parasite line expressing endogenously N-terminally tagged DDmyc-DGK1cKD stabilized by Shld-1 (Sidik et al., 2014) . Plaque assays of DDmyc-DGK1cKD minus Shld-1 reconfirmed the importance of TgDGK1 for parasite survival ( Figure 3K ), and IFAs showed that destabilization of the protein recapitulated the phenotype observed for the mycDGK1cKD strain +ATc ( Figure 3L ). Rather unexpectedly, the loss of parasite integrity also took time to manifest following shld-1 removal, suggesting that the phenotype, likely due to a detrimental imbalance of PA/DAG, takes time to build up ( Figure 3L , ÀShld-1). In parasites with only a marginal loss in membrane integrity, a gradual and significant impact of DGK1-destabilization on induced egress was noted ( Figure 3M ), and microneme secretion at these time points was also impaired ( Figure 3N ). Overall, these data clearly demonstrate the importance of PA generation by DGK1 to enact microneme secretion in T. gondii.
APH Acts as a PA Sensor and Is Essential for Microneme Secretion
Given that PA levels clearly impact microneme exocytosis, we sought to identify the protein sensor of PA at the parasite membrane. We completed bioinformatics searches in ToxoDB and PlasmoDB for pleckstrin homology (PH)-domain-containing proteins, as these domains are known to bind phosphoinositides. We found 14 genes containing predicted PH-domains in T. gondii and seven genes in Plasmodium (Table S1) (legend continued on next page) (ToxoDB: TGME49_249970), and it is this gene that formed the basis of our analysis ( Figure S3 ). In addition to a PH domain, the protein encoded by TGME49_249970 possesses an N-terminal stretch of 21 highly conserved residues with strong predictions for the presence of myristoylation (G2) and palmitoylation (C7) motifs ( Figures 4A-4C , S3A, and S3B). We termed this protein ''APH'' (acylated pleckstrin-homology domain) and revealed its localization to the micronemes with specific anti-APH antibodies ( Figure 4A , top panel). This localization was confirmed by generation of transgenic parasites expressing a ty-tagged second-copy (TgAPH-ty) ( Figure 4A middle panel, Figures S3C and S3D ). In addition, a fusion of the conserved N-terminal 21 residues of TgAPH to mCherry (N21-APH-mCh) localized to the micronemes ( Figure 4A bottom panel), and mutation of the putative acylation motifs (G2A or C7A) caused APH to redistribute throughout the parasite cytosol ( Figure 4B ). Overall, these data imply that APH is trafficked to the micronemes via palmitoylation/myristoylation within the first N-terminal 21 residues. Concordantly and as expected for a myristoylated/palmitoylated protein, TgAPH-ty was found to be insoluble in PBS and fully soluble in 1% Triton X-100 ( Figure 4C , left panel). In contrast, TgAPH myristoylation (G2A) and palmitoylation (C7A) mutants were found to be readily soluble in PBS ( Figure 4C , right panels). Lastly and consistent with acylation, protease protection assays confirmed that APH is localized to the outer micronemal surface ( Figure 4D ). It should be noted that all apicomplexan parasites possess micronemes and contain a highly conserved aph gene ( Figure S3B ) and thus are all likely to utilize this protein for the same role.
Confirmation that TgAPH binds PA was sought through both phosphoinositide-strip (PIP-strip) and liposome-binding assays . PIP-strips established that bacterially produced TgAPH and the PH-domain alone, the orthologous Plasmodium falciparum protein (PfAPH) and the yeast Spo20p WT/Mut proteins bind strikingly to PA and not as intensely to any other phosphoinositides ( Figure 4E ). In these assays an excess of protein is overlaid upon on an excess of lipid (100 pmol/spot); thus, we were unable to distinguish binding of the Spo20p WT/Mut to PA in vitro despite its clear specificity in vivo. We were however able to validate these results for APH via liposome binding assays, wherein the specificity of TgAPH, the PH-domain, and PfAPH binding to PA was confirmed and shown to be statistically significant (Figures 4F and 4G) . To further strengthen this data and assess directly how APH responds to changes in PA levels, we expressed a non-acylated, soluble form of APH by N-terminal fusion with DD (DDmyc-APH) and investigated its localization upon propranolol treatment ( Figures  4H/4I ). DDmyc-APH was found to re-localize to the parasite apex upon propranolol treatment, concordant with it binding to PA. This effect was ablated in the presence of DGK-inhibitor R59022 ( Figure 4H ), indicating that DDmyc-APH responds to the pool of PA produced specifically by DGK1 and enhanced by propranolol treatment.
Being refractory to genetic deletion, Tgaph was instead deleted by a gene excision strategy utilizing the rapamycindependent, dimerizable Cre-recombinase (Figures S3F-S3H ). Following addition of rapamycin, loss of Tgaph expression was seen in 10%-20% of the population ( Figure 5A , top panel). We were unable to clone any excised parasites, thus formally confirming that the Tgaph gene is essential. Within this system, removal of TgAPH did not alter microneme biogenesis, localization ( Figure 5A , bottom panel), or intracellular growth ( Figure S3H) ; however, concordant with a role in microneme secretion, Tgaph-excised parasites (ty-APH-cKO) displayed a marked block in invasion ( Figure 5B ) and egress ( Figure 5C ). The low excision rate precluded quantitative assessment of microneme secretion; therefore, we generated an additional conditional knockdown line both for completion of microneme secretion assays and also to confirm the data from the DiCre strain. As such, we generated an ATc-regulatable conditional knockdown of Tgaph (ty-APH-cKD) ( Figures S3I-S3K ).
(C) Endogenously C-(top) or N-terminally (bottom) tagged Tgdgk1 localizes to the parasite periphery. Scale bar 2mm. (D) myc-DGK1cKD parasites are regulated by ATc in 48 hr. GRA3: loading control. (E) myc-DGK1cKD but not parental DKU80 parasites display a severe growth defect in the absence of mycDGK1 (myc-DGK1cKD +ATc). (F) IFA of myc-DGK1cKD parasites ± ATc (48-96 hr). Upon myc-DGK1 removal, a pool of MIC2 mis-localizes to the parasite posterior (top right), the PPM degrades (SAG1, middle right), and rosette formation is perturbed (GRA3, bottom right). SAG1: PPM. GRA3: dense granule. Scale bar 2mm unless otherwise stated. (G) Electron micrograph of myc-DGK1cKD +ATc/72 hr. Parasite morphology is severely perturbed, and membranous whorls are seen within the vacuolar space. P: parasite. (H) mycDGK1cKD parasites transiently transfected with constructs expressing DDmycSpo20pGFP_WT (Spo20pGFP WT ) or DDmycSpo20pGFP_Mut (Spo20pGFP Mut ) were treated with Shld-1 ± ATc. In the absence of DGK1 (+ATc) Spo20pGFP WT translocates from the parasite periphery to the cytosol. There is no change in Spo20pGFP Mut localization either ± ATc. Scale bar 2 mm. (I) Total lipid was extracted from myc-DGK1cKD parasites grown in the presence (+ATc) or absence (ÀATc) of ATc. PA was separated from total lipid by HPTLC, quantified by GC-MS, normalized according to cell number, and shown relative to total fatty acid content (mol%). In myc-DGK1cKD parasites, the addition of ATc induced a decrease in PA (+ATc). (J) Similarly, the addition of DGK-inhibitor R59022 (30 mM) induced a decrease in PA in comparison to its control (DMSO). For both (I) Upon ATc treatment, ty-APH-cKD was efficiently depleted (Figure 5D ) and exhibited abrogated lysis plaque formation (Figure 5E) , impaired invasion ( Figure S3K ), and a block in egress ( Figure 5F ), thus confirming the ty-APH-cKO phenotype ( Figures  5A-5C ). Importantly, ATc-treated ty-APH-cKD parasites (Figure 5G , right panels) but not untreated ( Figure 5G , left panels) or TATi-1 parental parasites ( Figure S3L ) failed to secrete their micronemes when stimulated with A23187, ethanol, or propranolol, demonstrating that TgAPH is indeed essential for microneme exocytosis.
CONCLUSIONS
Previous studies have indirectly shown the importance of the PI-PLC pathway during microneme secretion signaling by focusing on the production of Ca 2+ (Carruthers et al., 1999; Lovett et al., 2002; Raabe et al., 2011) and the subsequent CDPK-dependent signaling cascade culminating in microneme exocytosis (Lourido et al., 2012; McCoy et al., 2012; reviewed in Holder et al., 2012; Garrison et al., 2012) . Here we have delved into the importance of DAG and PA generated by PI-PLC during this signaling cascade. Importantly, we have directly linked these specific signaling events to the microneme surface protein: APH, which is essential for microneme secretion, invasion, and egress. This function is likely conserved across the phylum, since APH is found in all apicomplexan parasites characterized to date ( Figure S3B ), including the less well studied Theileria spp. and Babesia spp., which also contain micronemes (Rudzinska et al., 1976; Schein et al., 1978) . We propose that following specific external stimuli such as changing potassium levels, PI-PLC activity is upregulated to produce more DAG, which is in turn converted to PA by DGK1. Concurrently, PI-PLC-generated IP 3 liposome bound proteins; fractions 3-5 contain unbound proteins. Immunoblots were probed with rabbit anti-APH or myc antibodies. stimulates Ca 2+ release, leading to CDPK activation. These events culminate in microneme fusion at the PPM, which is presumably enacted initially by APH binding to PA, ultimately facilitating the close apposition of the microneme to the PPM, DOC2.1 fusion, and eventually microneme exocytosis ( Figure 1A ).
While these data reveal the importance of APH and PA during microneme secretion, they also reveal the importance of DAG/ PA regulation during membrane signaling and homeostasis. Given the constitutive presence of low-level PA at the PPM, as indicated by Spo20p wt labeling, it is not surprising that conditional depletion of DGK1 or PI-PLC has a significant effect on overall parasite fitness. In other systems, DGK knockdown has been linked to apoptosis via lipid deregulation (Huang and Freter, 2015; Tsuchiya et al., 2015) ; thus, such an extreme phenotype upon PI-PLC or DGK1 depletion is to be expected and suggests that both PI-PLC and DGK1 functioning is important for maintaining diverse membrane signaling events not limited to microneme exocytosis. Such a role fits with the slight changes seen in PA levels detected upon DGK1 depletion. Furthermore, the conservation of DGK1 across the Apicomplexa ( Figure S1 ) and its relatively weak homology with its mammalian counterpart make it an ideal candidate for anti-parasitic intervention strategies.
DAG/PA generation is a reversible process, and we propose that the rapid conversion of PA back to DAG acts as the ''off switch'' during microneme secretion-dependent events such as gliding. This is supported by the effect of propranolol that indicates that blocking PAP activity with this compound prevents multiple independent rounds of secretion and promotes one single, large burst of microneme exocytosis ( Figure 1G ), thus overriding the ''off switch.'' The putative enzyme underpinning this step in T. gondii (PAP2, ToxoDB: TGME49_247360) ( Figure S4 ) is not conserved across the Apicomplexa and is only present within the coccidian subgroup of the phylum (http://toxodb. org/toxo/; Figure S4A) ; thus, additional PAPs may be involved in PA/DAG conversion throughout the phylum. Additionally, knockdown of TgPAP2 using the recently developed 3 0 UTR excision strategy revealed no significant lytic cycle defect, suggesting that this protein is either not essential or only a small amount (such as that remaining following knockdown) is required for maintaining PA/DAG homeostasis ( Figures S4B-S4H ). Other putative candidates for PAP functioning do however also exist within the Apicomplexa (Figure S4 ), and one of these other candidates could instead fulfil the role; however, this remains to be experimentally validated. In addition, other members of the Apicomplexa, such as Plasmodium merozoites, might not necessarily need to ''turn off'' microneme secretion while moving between host cells, and thus PAP activity is not necessarily an absolute requirement across the entire phylum. The significant phenotype generated by conditional depletion of Tgdgk1, and its conservation across the phylum, does however position it as a far more central target in the development of intervention strategies and thus of significantly greater importance.
In conclusion, the conservation of both DGK1 and APH, combined with data indicating that both PfAPH and TgAPH specifically bind PA and TgAPH localizes to the micronemes, strongly suggests that the pathway identified here is likely conserved across the phylum. These findings therefore greatly enhance our understanding of the signaling events underpinning apicomplexan microneme exocytosis and provide data on not solely the signaling events but also the protein sensors involved. Importantly, DGK1 and PI-PLC have been linked here to broader roles than purely enacting microneme exocytosis and ultimately highlight DGK1 as an apicomplexan-specific drug target underpinning essential lipid signaling-related events in this important group of pathogens.
EXPERIMENTAL PROCEDURES Antibodies
Rabbit anti-APH, rabbit anti-GAP45 (Plattner et al., 2008) , mouse anti-Ty (BB2), mouse anti-Myc (mAb9E10), mouse anti-MIC2, mouse anti-SAG1, mouse anti-GRA1 (Sibley et al., 1995) , rabbit anti-ARO (Mueller et al., 2013) , rabbit anti-Catalase (Ding et al., 2000) , and rabbit anti-Profilin (also used for GST-detection in PIP-strip assays) (Plattner et al., 2008) .
Proteinase K Protection Assay
Freshly egressed T. gondii tachyzoites were resuspended in 1.5 ml cold SoTE (0.6 M sorbitol, 20 mM Tris-HCl [pH 7.5], and 2 mM EDTA) and split into three tubes (0.5 ml each). Cold SoTE was added to tube 1 as a control. Tubes 2 and 3 were permeabilized with 0.5 ml cold 0.01% digitonin (Sigma)/SoTE. Samples were carefully mixed by inversion and incubated on ice/10 min prior to centrifugation (2,000 3 g/4 C/10 min). Supernatant was discarded, and 0.5 ml cold SoTE was added to tube 1, while 2.25 ml of cold Proteinase K (Sigma, 20 mg/ml)/SoTE was added to tube 3. All tubes were gently inverted and incubated on ice/30 min. Proteinase K was inactivated by addition of cold trichloroacetic acid to a final concentration of 10% on ice/30 min. Samples were centrifuged (14,000 rpm/20 min), washed 23 with acetone, air dried, and resuspended in TE prior to SDS-PAGE.
IFA HFF monolayers grown on coverslips were inoculated with tachyzoites and grown at 37 C. Cells were subsequently fixed with 4% paraformaldehyde (PFA) or 4% PFA/0.05% glutaraldehyde (PAF/Glu) for 10 min, then quenched with 0.1 M glycine/PBS. Cells were permeabilized (0.2% Triton X-100/PBS), blocked (2% BSA/0.2%Triton/PBS), and probed with primary antibodies (60 min) prior to washing (0.2%Triton/PBS) and incubation with secondary antibodies (Alexa488-or Alexa594-conjugated goat anti-mouse/rabbit). Nuclei were stained with DAPI, and coverslips were mounted in FluoromountG. Image analysis was done using an LSM 700 confocal scanning microscope (Zeiss).
Microneme Secretion Assay
Freshly egressed parasites were resuspended in equal volume intracellular (IC) buffer (5 mM NaCl, 142 mM KCl, 1 mM MgCl 2, 2 mM EGTA, 5.6 mM glucose, 25 mM HEPES, pH to 7.2 with KOH) prior to pelleting (1,050 rpm/10 min). Pellets were subsequently washed in IC buffer and re-pelleted before resuspension in serum-free media with listed pre-treatment compounds for 30 min/room temperature (RT). After pre-treatment, parasites were pelleted and resuspended in serum-free medium and DMSO, 500 mM propranolol, 2% ethanol, 500 mM zaprinast, or 3 mM A23187 (37 C/5-30 min). Parasites were pelleted (1,000 3 g/5 min/4 C), and supernatant was transferred to new Eppendorf tubes and re-pelleted (2,000 3 g/5 min/4 C). Final supernatant (excreted secreted antigens [ESAs] ) and pellet fractions were resuspended in sample buffer (50 mM Tris-HCl [pH 6.8], 10% glycerol, 2 mM EDTA, 2% SDS, 0.05% bromophenol blue, 100 mM DTT) and boiled prior to analysis by immunoblotting. For Figure 1F , parasites were resuspended in 100 ml IC buffer ± 500 mM propranolol (37 C/30 min). Samples were spun as above, and supernatant was collected (Intra. Figure 1F ). Pellets were resuspended in 100 ml serumfree media ± 500 mM propranolol (37 C/30 min), pelleted as before, and supernatant was collected (Extra. Figure 1F ). Final pellet was resuspended in 100 ml serum free medium ± 500 mM propranolol +2% ethanol, pelleted, and supernatant was collected (Extra +EtOH, Figure 1F ).
Protein-Lipid Overlay Assay
PIP-strip (Echelon Biosciences) assays were carried out according to manufacturer's instructions. Briefly, strips were incubated (1 hr) in PBST/BSA (PBS, 0.1% Tween 20, 3% BSA) prior to incubation with 0.5 mg/ml of each protein for 1 hr. Strips were washed 3 3 10 min with PBS/0.1% Tween before incubation with specific antibodies for 1 hr/RT. PIP-strips were subsequently washed and probed with specific secondary antibodies.
Liposome Binding and Membrane Flotation Assay
Lipids (Avanti Polar Lipids Inc.); 1-pamitoyl-2-oleoyl-sn-glyero-3-phosphocholine (POPC), 1-pamitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (POPS), and 1-pamitoyl-2-oleoyl-sn-glycero-3-phosphate (POPA) were solubilized in chloroform, mixed, and vortexed in tubes at specific ratios (PC = 100 mol% PC; PS/PC = 50 mol% PC and 50 mol% PS; PA/PC = 50 mol% PC and 50 mol% PA). Chloroform was evaporated under N 2 . Dried lipids (2 mmol) were hydrated for 30 min in 1 ml of lipid rehydration buffer (100 mM NaCl, 1 mM CaCl 2 , and 50 mM Tris-Cl [pH 7.4]) prior to three freeze/thaw cycles and extrusion through 4 mm pore-size filters using a mini-extruder (Avanti Polar Lipids) to produce liposomes. For binding assays, liposomes (200 nmol) were incubated with 500 pmol recombinant protein (37 C/1 hr) in a final volume of 100 ml. Reaction mixture was subsequently diluted to 200 ml with 85% sucrose, then layered with 2.8 ml 65% sucrose and 1 ml 10% sucrose, and centrifuged (115,000 3 g/4 C/16 hr).
Sucrose solutions were prepared in buffer containing 100 mM NaCl, 50 mM Tris-Cl (pH 7.4). Five 1 ml fractions were collected from the top of each tube and were analyzed by immunoblot. Band intensity was quantified using an Odyssey imaging system (Li-Cor Inc.). Liposome binding efficiency was calculated as % of bound = bound/(bound + unbound) * 100. (Tanaka et al., 2012) . The spot corresponding to PA (identified according to migration of authentic PA standard) was then extracted for quantification of fatty acids by GC-MS (Agilent 5977A-7890B) after methanolysis (MacRae et al., 2012) . Fatty acid methyl esters were identified by their mass spectrum and retention time and quantified by the calibration curve generated by fatty acid methyl ester standards. PA content was normalized according to parasite cell number and a C13:0 internal standard. An increase in calcium was seen in parasites treated with A23187 and ethanol, but treatment with propranolol or DMSO did not stimulate and increase in calcium.
PA Extraction and Quantification
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Supplemental CGACGAAGACGAAGACGTCTGTCTCTCCATT TTGATATCCCTAGGAATTC 5636; Forward primer to check integration of PI-PLC-ty (Fig S2A primer a) TTCTTTCTCCTTTTTCTCTCTCCTC 5711; Reverse primer to check integration of PI-PLC-ty (Fig S2A primer b) CCGCGACTGCCTACCAATACCCGTT M13F; Forward primer to confirm integration of PI-PLC-ty (Fig S2A primer d) GTAAAACGACGGCCAGT 5635; Reverse primer to check integration of PI-PLC-ty (Fig S2A primer e) TCTCTGACAAATCACTTCTTCCTCT 5771; Forward primer to check integration of PI-PLC-ty iKO (Fig S2C primer A) GAAGGAAGCGAGGAGAGAAGTGAGGTTCG A 5770; Reverse primer to check integration of PI-PLC-ty iKO (Fig S2C primer B) GGAGATCTTTGATGCGTTGACTGACGACGG 4566 ; DGK1 forward primer for TY knock-in CCGGGTACCTGAGAGAAAGAAAGAGACAG AGGGAAG 4567; DGK1 reverse primer for TY knock-in GGCATGCATACGCATGCAAGTGTTTGTCGCA AG 4786; Forward primer to check integration of DGK1-TY KI. (Fig S2E primer a) GTTTCTTTCTTTCCCCTCCGTCAC 4874; Reverse primer to check integration of DGK1-TY KI. (Fig S2E primer b) GCCTCCGAAGTTACATGCACAG P30A; Reverse primer in KI plasmid (Fig S2A  primer c; Fig S2E primer c; Fig S5B primer (Fig S4A primer D) GCCCACGACAGCAGACAACTTTCC 1602; Reverse primer to check 5'UTR integration for ty-APH-cKD (Fig S4D primer  F) CCGTCGACACACGCGCCACATGGG 3979; Forward primer to check 3'UTR integration for ty-APH-cKD (Fig S4D primer  D) ACACAAGGTGATTGTGTAACACCG 4034; Forward primer for screening ty-APHcKO (Fig S4A primer c; Fig S4D primer A) CCGGGTACCGAGCTCGCACACACAAAACTG 4035; Reverse primer for screening ty-APHcKO (Fig S4A primer B; Fig S4D primer (Fig S4D primer C Fig  S4A) CAGTCATGTAACTGCAGAGTTGTGC 4440; Reverse primer for checking the correct integration of DiCre TgAPH (Fig S4A primer  E) . 
GCCATGCATGCAAATTACTGCATTTGCGTTC ACTATC
4873;
Reverse primer to check integration of PAP-ty knock-in and PAP-ty 3'UTR-LoxP ( Fig  S5, primer b) . CACTCAACCAACCTTCAGCGTAG 4590; Forward primer to check integration of PAP-ty knock-in and PAP-ty 3'UTR-LoxP ( Fig  S5, primer a) . 
GGCATGCATATGACTGAGCAGGAAAAAGTT GAGG
4812; Forward primer with
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Parasite culture:
T. gondii tachyzoites (RH hxgprt-ko, ΔKU80, TATi-1 (Meissner, Schlüter, & Soldati, 2002) or ΔKU80::DiCre strains Huynh & Carruthers, 2009 )) were grown in human foreskin fibroblast (HFF) monolayers in Dulbecco's Modified Eagle's Medium (DMEM, GIBCO) supplemented with 5% fetal calf serum (FCS), 2 mM glutamine and 25 µg/ml gentamicin (37°C, 5% CO 2 ). Parasite transfections were performed by electroporation as described previously (Soldati & Boothroyd, 1993) . The hypoxanthine-xanthine-guanine phosphoribosyl transferase (hxgprt) (Donald, Carter, Ullman, & Roos, 1996) and dihydrofolate reductasethymidylate synthase (dhfr-ts) genes (Donald & Roos, 1993) were used as positively selectable markers as described previously.
T. gondii cloning strategies
TgPI-PLC-ty
To generate endogenously ty-tagged Tgpiplc (TgPIPLC-ty) fragments were generated with Q5 (NEB) DNA polymerase using primers outlined in Table S2 . Fragments were cloned into KpnI/NsiI sites of the pTUB8MIC13-3Ty-HX vector (11) and linearized with NdeI prior to transfection (20µg). Parasites were selected by Myocophenolic acid (MPA)/Xanthine and clones were obtained by limiting dilution. Correct integration was confirmed by PCR of genomic DNA using primers listed in Table S2 .
TgPI-PLC-ty cKD
To generate the TgPI-PLC-ty cKD strain, a PCR product of 5'COR-pT8TATi1
HXtet07S1mycNtCOR plasmid (12) with approximately 30bp homology to Tgpiplc was generated with KOD polymerase (Novagen) using primers listed in Table S2 . A Cas9/CRISPR guide targeting the N-terminus of Tgpiplc was generated using Q5 mutatgenesis (NEB) and primers listed in Table S2 . Following transfection, green fluorescent parasites were cloned into 96 well plates. Regulatable clones were subsequently ty-tagged at the endogenous locus as outlined above. Correct integration was confirmed by PCR of genomic DNA using primers listed in Table S2 .
TgDGK1-ty
To generate endogenously ty-tagged Tgdgk1 (TgDGK1-ty) fragments were generated with Phusion (NEB) DNA polymerase using primers outlined in Table S2 . Fragments were cloned into KpnI/NsiI sites of the pTUB8MIC13-3Ty-HX vector (Friedrich et al., 2010) and linearized with StuI prior to transfection (20µg). Parasites were selected by MPA/Xanthine and clones were obtained by limiting dilution. Correct integration at both sites was confirmed by PCR of genomic DNA using primers listed in Table   S2 .
myc-DGK1cKD
To generate the myc-DGK1cKD plasmid, 5'flanking and N-terminal homology regions were amplified from ΔKU80 strain parasites using primers indicated in Table   S2 . Briefly, a 1930bp region of genomic DNA corresponding to the 5' flanking region upstream of the Tgdgk1 start codon and a 667bp region of genomic DNA corresponding to the N-terminal Tgdgk1 region from the codon 3' to the ATG were cloned into NcoI/BamHI and BglII/NotI sites in the 5'COR-pT8TATi1-HXtet07S1mycNtCOR plasmid (Salamun, Kallio, Daher, Soldati-Favre, & Kursula, 2014) , respectively. Prior to transfection (100µg) into ΔKU80 parasites, the vector was linearized with SbfI. Parasites were selected with MPA/Xanthine and clones were obtained by limiting dilution. Correct integration at both sites was confirmed by PCR of genomic DNA using primers listed in Table S2 .
DD/HA-DGK1cKD
To generate the DDHA-DGK1 plasmid, Tgdgk1 cDNA was amplified by PCR with Phusion DNA polymerase using primers indicated in Table S1 . PCR product was inserted into the pTub8DDHAGFP-HX construct between NsiI/PacI sites. This construct was transfected into both RH (DD/HA-DGK1cKD) and myc-DGK1cKD (myc-DGK1cKD (comp. DD/HA-DGK1cKD)) strains where it was maintained as a second copy. Expression of DD/HA-DGK1 was controlled by addition or removal of Shld-1.
DDmyc-DGK1cKD
The Cas9/CRISPR system combined with a PCR product generated using primers listed in Table S2 was utilized to generate endogenously N-terminally DDmyc-tagged dgk1 (DDmyc-DGK1cKD) and positive clones were generated. Expression of DDmyc-DGK1 was subsequently regulated by addition or removal of Shld-1.
Spo20pGFP wt/mut
The PA-binding region of the yeast SNARE protein Spo20p (Spo20p WT , amino acids 51-91) and mutated Spo20p (Spo20p mut , amino acids 51-91, S69P and L67P mutations) coding sequences were amplified by PCR with Phusion DNA polymerase using the vectors GFP-Spo20P WT and GFP-Spo20p mut (kindly provided by N. Vitale (Zeniou-Meyer et al., 2007) ) respectively, as templates. PCR products were inserted into the pTub8DDmycGFP-HX construct between PstI and PacI sites. Expression was regulated by addition of Shield for 4hrs. 
TgAPH-ty
Primers for
TgAPH-ty (G2A, C7A)
Mutation of the putative acylation sites (G2A, C7A) in the pTub8TgAPH-ty-HX strain were obtained by PCR amplification. Mutants were verified by DNA sequencing and subsequently referred to as TgAPH-ty-G2A or TgAPH-ty-C7A.
N21-APH-mCherry
The TgAPH-N21-mCherry-ty-HX fusion construct was generated by first amplifying the sequence encoding the first N-terminal 21 amino acids of Tgaph and subsequently inserting this fragment into the pTub8TgPRF-mCherry-ty-HX construct between EcoRI/NsiI sites to generate N21-APH-mCherry parasites.
DDmyc-APH
To generate the DDmyc-APH plasmid, aph cDNA was PCR amplified with Phusion DNA polymerase using primers indicated in Table S2 . PCR product was inserted into the pTub8DDmycGFP-HX construct between NsiI/PacI sites. Clonal DDmyc-APH strain was obtained by HXGPRT drug selection and cloning by limiting dilution.
Expression was regulated by the presence of Shld-1 for 4 hrs. For DDmyc-APH relocalisation studies, freshly egressed DDmyc-APH parasites were treated with either DMSO or 30 µM R59022 for 30mins, followed by treatment with Propranolol (100 µM) for 10 mins.
ty-APH-Lox/ty-APH -cKO
Tgaph cDNA (with LoxP sequence added to its 5') was subcloned from pTub8ty-APH-HX and inserted into the Tub8-loxP-KillerRed-loxp-YFP-HX plasmid between EcoRI/PacI. Five prime and 3' fragments (~2 kb each) of Tgaph were amplified by PCR and subsequently cloned into of the Tub8-loxP-ty-APH-loxp-YFP between KpnI/EcoRI and SacI sites respectively. The final construct 5'APH-loxP-ty-APH-loxP-YFP-3'APH-HX was linearized with BglII/NcoI prior to transfection to generate the ty-APH-Lox strain. To generate ty-APH-cKO, ty-APH-Lox parasites were treated with rapamycin overnight.
ty-APH-cKD
To make the ty-APH-cKD (ATc-inducible) strain, ty sequence was inserted into the Tgaph coding sequence after the N-terminal 21 amino acids. This was sub-cloned into TetO7Sag4YFP between EcoRI/PacI sites. The DHFR-TS selection cassette was then cloned between SacI sites to generate the final ty-APH-cKD. To delete the endogenous Tgaph, 5' and 3' TgAPH fragments (~2.5 kb each) were PCR amplified using primers listed in Table S2 and subsequently cloned into of the pTub5CATSag1 plasmid using NotI/SpeI and KpnI/XhoI sites respectively. The final construct 5'APHpTub5CATSag1-3'APH was linearized with SbfI/SmaI prior to transfection to generate ty-APH-cKD parasites.
TgPAP2-ty KI
To generate endogenously ty-tagged Tgpap2 (TgPAP2-ty) fragments were generated with Phusion (NEB) DNA polymerase using primers outlined in Table S2 . Fragments were cloned into KpnI/NsiI sites of the pTUB8MIC13-3Ty-HX vector (11) and linearized with PstI prior to transfection (20µg). Parasites were selected by MPA/Xanthine and clones were obtained by limiting dilution. Correct integration was confirmed by PCR of genomic DNA using primers listed in Table S2 .
TgPAP-ty cKD
To generate the TgPAP2ty cKD plasmid, fragments were generated with Phusion (NEB) DNA polymerase using primers outlined in Table S2 . Fragments were cloned between KpnI/NsiI sites of pLIC-HA-FLAG-flox (3'UTR-SAG1-HXGPRT)-4xU1 for C-terminal knock-in of three ty tags and U1-mediated silencing Rugarabamu, Marq, Guérin, Lebrun, & Soldati-Favre, 2015) . The resultant plasmid was termed PAP-ty_3'UTR-SAG1-HXGPRT. Plasmid DNA (80µg) was digested with PstI prior to transfection (80µg) in DiCre expressing parasites, prior to cloning by limiting dilution. Correct integration was confirmed by PCR of genomic DNA using primers listed in Table S2 . Parasite clones were subsequently referred to as PAP2ty LoxP. To generate TgPAP2-ty cKD strain parasites, extracellular PAP2-ty LoxP parasites were treated for 4hrs with 50nM rapamycin prior to cloning by limiting dilution. Correct integration was confirmed by PCR of genomic DNA using primers listed in Table S2 . Resultant parasite strain is referred to as PAP2ty KD.
Electron microscopy myc-DGK1cKD or PI-PLC-ty cKD parasites were grown in ATc for 48hrs and upon egress were transferred to fresh HFF monolayers in the presence of ATc. 24hrs later cells were fixed for electron microscopy using standard procedures (total 72hrs ATc treatment). Briefly, infected HFF monolayers were fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer pH 7.4, post-fixed in osmium tetroxide, dehydrated in ethanol and treated with propylene oxide prior to embedding in Spurr's epoxy resin. Thin sections were stained with uranyl acetate and lead citrate prior to examination using a Technai 20 electron microscope (FEI Company).
Intracellular growth assay
HFF monolayers were inoculated with freshly egressed parasites and incubated for 24hrs before fixation with PAF/Glu. IFAs were completed using α-GAP45 to detect individual parasites. Results represent mean +/-standard deviation of 100 parasites counted in triplicate from three biological replicates.
Induced egress assay
Freshly egressed parasites were inoculated on HFF monolayers and incubated for 30-32hrs. For R59022 experiments, cells were incubated with specified concentrations of R59022 or DMSO at room temperature for 30mins prior to stimulation of egress. For ty-APH-cKO assays, extracellular parasites were treated with rapamycin (50 mM) for 4hrs and then allowed to grow for forty-eight hours to ensure excision of ty-APH.
Freshly egressed parasites were grown for 30hrs on fresh HFF monolayers. Egress was stimulated by serum free media containing 3µM A23187, 500µM propranolol or 0.06% DMSO as a control at 37°C/8mins prior to fixation. Cells were labelled with GAP45 and the proportion of egressed versus non-egressed vacuoles was calculated by counting 100 vacuoles in triplicate for three independent experiments. For the ty-APH-cKO the average number of vacuoles with parasites expressing YFP and non-YFP which had egressed was determined by counting 100 vacuoles in duplicate for three independent experiments.
Invasion assay R59022 and propranolol invasion assays were completed by pre-incubating extracellular parasites with inhibitors at room temperature for 30mins at concentrations consistent with other R59022 (Nobe et al., 2004 ) and propranolol inhibition studies. Parasites were subsequently inoculated on HFF monolayers and allowed to invade for 1hr at 37˚C. Monolayers were subsequently fixed and invasion was monitored by standard red/green invasion assays (Rugarabamu et al., 2015) .
For the ty-APH-Lox and ty-APH-cKO strains, invasion assays were performed using the non-YFP expressing parasites as an internal control. Extracellular ty-APH-Lox parasites were treated with 50 mM rapamycin for 4hrs prior to their inoculation on HFF monolayers. Forty-eight hours later, freshly egressed parasites were passed on HFF monolayers and allowed to invade for 60mins at 37˚C, prior to washing of monolayers. Cells were subsequently grown for a further 24hrs to determine the ratio of YFP (ty-APH-cKO): non-YFP (ty-APH-Lox) parasites.
Parasites were stained with α-GAP45 antibodies and the ratio between YFP and non-YFP parasite-containing vacuoles was calculated. Results represent mean +/-standard deviation of 50 parasites counted in triplicate from six biological replicates.
Gliding assays
Freshly egressed parasites were washed in serum free media and inoculated onto gelatin-coated coverslips. 2% ethanol, 500/250/200µM propranolol, or 30µM R59022 was added to cells prior to incubation at 37˚C/30mins. Media was removed and parasites were fixed with PAF/Glu prior to non-permeabilising IFA and staining with anti-SAG1 antibodies.
Plaque assays
Freshly egressed parasites were inoculated on HFF monolayers +/-anhydrotetracycline (ATc). Parasites were grown for seven days prior to fixation with PAF/Glu (as outlined previously) and subsequent staining with crystal violet.
Recombinant protein purification N-terminal GST-fusion proteins of full length TgAPH and the TgAPH PH domain, as well as Spo20p WT/Mut were cloned using BamHI /XhoI sites of the pGEX-4T plasmid using primers outlined in Table S2 . Polyclonal antibodies to TgAPH were obtained by immunizing rabbits with the recombinant full-length protein purified from E. coli. 
